# Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer

> **NCT07016438** · NA · RECRUITING · sponsor: **PharmaBio Corporation** · enrollment: 6 (estimated)

## Conditions studied

- Refractory Skin Ulcer

## Interventions

- **PROCEDURE:** Transplant surgery

## Key facts

- **NCT ID:** NCT07016438
- **Lead sponsor:** PharmaBio Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07016438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07016438, "Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07016438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*